Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 2/20 | 0.51 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.51 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.51 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.50 |
| ▸ | DRD3 | P35462 | 3/20 | 0.50 |
| ▸ | DRD2 | P14416 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.46 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.46 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.46 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.46 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.46 |
| ▸ | DRD4 | P21917 | 2/20 | 0.46 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.46 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.46 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.46 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphonic Acid SCHEMBL29035527 | 0.92 | CHRM2 (0.46) | CHRM2CHRM1CHRM3OPRM1DRD3 | |
| SCHEMBL27965739 | 0.90 | ESR1 (0.52) | CHRM2CHRM1CHRM3OPRM1DRD3 | |
| SCHEMBL10452446 | 0.89 | KCNN4 (0.51) | CHRM2CHRM1CHRM3OPRM1DRD3 | |
| SCHEMBL3391343 | 0.89 | OPRM1 (0.47) | CHRM2CHRM1CHRM3OPRM1DRD3 | |
| SCHEMBL11752498 | 0.86 | CHRM2 (0.51) | CHRM2CHRM1CHRM3OPRM1DRD3 | |
| SCHEMBL19031877 | 0.86 | CYP19A1 (0.43) | CHRM2CHRM1CHRM3OPRM1DRD3 | |
| SCHEMBL27965917 | 0.86 | ESR1 (0.47) | CHRM2CHRM1CHRM3OPRM1DRD3 | |
| 1-Hexanol SCHEMBL28322314 | 0.84 | LMNA (0.42) | CHRM2CHRM1CHRM3OPRM1DRD3 | |
| SCHEMBL4030430 | 0.83 | MAPT (0.55) | CHRM2CHRM1CHRM3OPRM1DRD3 | |
| SCHEMBL20607354 | 0.83 | OPRM1 (0.66) | CHRM2CHRM1CHRM3OPRM1DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| US-20250221954-A1 | METHODS TO TREAT, PREVENT, OR REDUCE HYPERAMMONEMIA | RUBIN DARREN ALEXANDER (US) | 2025-07-10 | — | — | US | claimed |
| EP-3689849-B1 | PERFUME PRECURSOR | TAKASAGO PERFUMERY CO LTD (JP) | 2025-01-15 | — | — | EP | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| EP-3966384-B1 | FRESHENING COMPOSITIONS WITH ALKOXYLATED PHENOLS | PROCTER & GAMBLE (US) | 2023-05-03 | — | — | EP | claimed |
| EP-2708592-B2 | Fabric care composition | PROCTER & GAMBLE (US) | 2022-03-16 | — | — | EP | claimed |
| EP-3423028-B1 | METHOD FOR THE PRODUCTION OF ENCAPSULATED FRAGRANCE WITH IMPROVED STABILITY AGAINST DETERGENTS | SYMRISE AG (DE) | 2020-04-08 | — | — | EP | claimed |
| EP-2708592-B1 | Fabric care composition | PROCTER & GAMBLE (US) | 2019-02-13 | — | — | EP | claimed |
| EP-3423028-A1 | METHOD FOR THE PRODUCTION OF SCENT CAPSULES WITH IMPROVED SURFACTANT STABLITY | Symrise AG (DE) | 2019-01-09 | — | — | EP | claimed |
| US-10072043-B2 | Inhibitors of protein tyrosine phosphatases | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2018-09-11 | — | — | US | claimed |
| EP-0805673-A1 | PERSONAL TREATMENT COMPOSITIONS AND/OR COSMETIC COMPOSITIONS CONTAINING ENDURING PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 1997-11-12 | — | — | EP | claimed |
| EP-0790820-A1 | PERSONAL TREATMENT COMPOSITIONS AND/OR COSMETIC COMPOSITIONS CONTAINING ENDURING PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 1997-08-27 | — | — | EP | claimed |
| EP-0787177-A1 | DETERGENT COMPOSITIONS CONTAINING ENDURING PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 1997-08-06 | — | — | EP | claimed |
| US-5540853-A | CLEANING COMPOUNDS, PERFUMES, SURFACTANTS AND CARRIERS | THE PROCTER & GAMBLE COMPANY (US) | 1996-07-30 | — | — | US | claimed |
| WO-1996012786-A1 | DETERGENT COMPOSITIONS CONTAINING ENDURING PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 1996-05-02 | — | — | WO | claimed |
| WO-1996012467-A1 | PERSONAL TREATMENT COMPOSITIONS AND/OR COSMETIC COMPOSITIONS CONTAINING ENDURING PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 1996-05-02 | — | — | WO | claimed |
| WO-1996012468-A1 | PERSONAL TREATMENT COMPOSITIONS AND/OR COSMETIC COMPOSITIONS CONTAINING ENDURING PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 1996-05-02 | — | — | WO | claimed |
| US-5500138-A | QUATERNARY AMMONIUM COMPOUND, LONG LASTING PERFUME, BETTER DEPOSITION ON FABRICS | THE PROCTER & GAMBLE COMPANY (US) | 1996-03-19 | — | — | US | claimed |
| US-5500137-A | Fabric softening bar compositions containing fabric softener and enduring perfume | THE PROCTER & GAMBLE COMPANY (US) | 1996-03-19 | — | — | US | claimed |
| EP-0147191-B1 | PERFUME AND COMPOSITIONS CONTAINING PERFUME | UNILEVER N.V. (NL) | 1989-10-04 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10072043-B2 | Inhibitors of protein tyrosine phosphatases | PTPRCAP, PTPRF, PTPRS | CHRM2 4876/4885CHRM1 4869/4885CHRM3 4872/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.